In the News

My Personal Therapeutics and Medivizor Announce a Collaboration Agreement

Aug 31, 2020

My Personal Therapeutics to Test Fruit Fly Avatar Technology in Gastrointestinal Cancer Patients

July 24, 2020

My Personal Therapeutics awarded grant from Innovate UK to collaborate with the NIHR - London In Vitro Diagnostic Co-operative to provide personalised treatment to patients with Gastro-Intestinal Cancer

July 15, 2020

My Personal Therapeutics Appoints Jon Waterman-Smith as Vice President of Business Development

July 1, 2020

My Personal Therapeutics and Pentavere scoop funding for lung cancer digital therapeutics

July 3, 2020

My Personal Therapeutics (MPT) and Acindes announce an exclusive collaboration agreement

Apr 27, 2020

GHP News 2020 Biotechnology Awards Winners

Apr 14, 2020

Building avatar armies with fish and flies

March 24, 2020

Silicon Valley pone en su podio a My Personal Therapeutics: tratamiento de cáncer personalizado

March 9, 2020

myTomorrows collaborates with My Personal Therapeutics

February 19, 2020

Get ready for Global: 7 exciting startups to look out for.

Feb 7, 2020

A personal “flybrary”

January 27, 2020

London startup enlists fruit flies in fight against cancer

Nov 25, 2019

Scientists used fruit flies to quickly develop a personalized cancer treatment for a dying man

September 13, 2019

Are fruit fly 'avatars' the next step in personalized medicine?

May 24, 2019

Specially created animal 'cancer avatars' could personalise treatments

22 May, 2019

10 to Watch: Up-and-coming companies fulfilling the promise of precision medicine

May 22, 2019

Fruit fly model provides personalized cancer therapy recommendation

May 22, 2019

A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer

May 22, 2019

My Personal Therapeutics announces funding and secures exclusive Mount Sinai School of Medicine technology license to revolutionize personalized cancer treatment

April 30, 2019

My Personal Therapeutics announces funding and secures exclusive Mount Sinai School of Medicine technology license to revolutionize personalized cancer treatment

Apr 12, 2019